Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?
Severity assessment of patients with haemophilia A (HA) is traditionally based on FVIII activity (FVIII:C). Clinical phenotype of HA patients often differs between individuals with the same FVIII:C determined with clotting and chromogenic assays. The aim of this study was to assess the influence of the FVIII:C on thrombin generation (TG) assay parameters both in vitro and ex-vivo postinfusion plasma. For in-vitro approach, influence of FVIII:C was evaluated on TG parameters in several dilutions of a normal plasma pool with commercial FVIII-depleted-plasma (FVIIIDP) and in others experiments, adding increasing amounts of different commercial FVIII concentrates (Fanhdi, Haemate-P, Hemofil-M and Kogenate Bayer) to FVIIIDP. In a series of 50 postinfusion samples, from HA patients of different severity, we assayed TG and FVIII:C (chromogenic and clotting). In vitro experiments, the 50% of maximum TG peak (TGMP) was achieved using only 5% FVIII:C and the TGMP was obtained with 40% of normal VIII:C. Impaired response compared with normal plasma was found in FVIIIDP using addition of increasing amounts of different commercial FVIII concentrates. An overall good correlation between the two FVIII assays was observed (y = 0.9115x - 0.273, r = 0.975, P < 0.001); TGMP and the Lag-Phase-Time (LPT) provided some discrepant results when compared with the total range of FVIII:C measurements. In contrast, correlations for TGMP, LPT and endogenous thrombin potential were improved in samples restricted to FVIII:C <5%. We conclude that TG parameters tentatively could be a tool to tailor the global haemostatic capacity in haemophilic patients.
Salvagno
G L
GL
Department of Clinical Chemistry, Verona University Hospital, Verona, Italy. gsalvagno77@yahoo.it
Astermark
J
J
Lippi
G
G
Ekman
M
M
Franchini
M
M
Guidi
G C
GC
Berntorp
E
E
D001780:Blood Coagulation Tests / Q000379:methods*; D001800:Blood Specimen Collection / Q000379:methods; D005169:Factor VIII / Q000032:analysis*; D006467:Hemophilia A / Q000097:blood*; D006801:Humans; D008297:Male; D013917:Thrombin / Q000096:biosynthesis*
D005169:Factor VIII; D013917:Thrombin